Clinical Trial Update: Study of Pharmacokinetics, Pharmacodynamics, Safety of BCD-131 Compared to Mircera and Aranesp in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study assessing pharmacokinetics, pharmacodynamics, and safety of BCD-131 compared with Mircera and Aranesp in healthy volunteers has completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Reticulocyte Count

Drugs mentioned

• ARANESP (DARBEPOETIN ALFA)
• BCD-131
• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Biocad | Conditions: Reticulocyte Count | Phase 1 | Status: COMPLETED | Results posted: 2019-07-01